Literature DB >> 21677287

Interleukin-17 and atherosclerotic vascular disease.

Jordan S Pober.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21677287     DOI： 10.1161/ATVBAHA.111.228338

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  4 in total

Review 1.  Highlights of 10 years of immunology in Nature Reviews Immunology.

Authors:  Ruslan Medzhitov; Ethan M Shevach; Giorgio Trinchieri; Andrew L Mellor; David H Munn; Siamon Gordon; Peter Libby; Göran K Hansson; Ken Shortman; Chen Dong; Dmitry Gabrilovich; Leona Gabryšová; Ashleigh Howes; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

Review 2.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

Authors:  Peter Libby; Andrew H Lichtman; Göran K Hansson
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

3.  Interleukin 17A in Patients With Stable Coronary Artery Disease: Are There Differences According to Gender?

Authors:  Dinaldo Oliveira; Elayne Heide; Carlos Brandt; Moacyr Rego; Maira Pitta; Ivan Pitta
Journal:  Cardiol Res       Date:  2014-12-04

4.  The significance of Agaricus blazei as an immunomodulator of the level of IL-17 in Balb/C mice with atherosclerosis.

Authors:  Dicky Kurniawan Tontowiputro; Djanggan Sargowo; Askandar Tjokroprawiro; Muhaimin Rifa'i
Journal:  Cent Eur J Immunol       Date:  2020       Impact factor: 2.085
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.